Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus

Completed

• Conditions: Diabetes Mellitus
• Interventions: Other: There is no intervention.

• Registration Number: NCT03455101
• Lead Sponsor: Gulhane School of Medicine

Brief Summary

This study evaluates the overall cardiovascular risk status and best predictors of optimal metabolic control of Turkish adult patients with diabetes mellitus.

Detailed Description

Diabetes mellitus is one of the most common chronic diseases with an increasing prevalence worldwide.The prevalence of diabetes is also increased significantly in Turkey, from 7.2 % in 2002 to 13.7% in 2012.This increasing prevalence leads to serious public health problems and a significant economic burden. Therefore, the optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important. As there is hardly enough data about glycemic and other metabolic control parameters in Turkish adult patients with type 1 or type 2 diabetes, this nationwide survey was performed.

Study Timeline

• Study Start: 2017-04-01
• Primary Completion: 2017-06-30
• Study Completion: 2017-06-30
• Study First Submitted: 2017-09-24
• Status Verified: 2018-02
• Study First Submitted QC: 2018-02-27
• Last Update Submitted: 2018-02-27
• Study First Posted: 2018-03-06
• Last Update Posted: 2018-03-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5240

Inclusion Criteria

• Patients with type 1 or type 2 diabetes
• Upper than 18 years old
• To be under follow-up in the same center for at least one year.

Exclusion Criteria

• Pregnancy
• Younger than 18 years old,
• History of decompensated liver disease,
• History of psychiatric disorders interfering cognition or compliance
• History of bariatric surgery
• History of renal replacement therapy.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with diabetes mellitus	There is no intervention.	Patients with type 1 or type 2 diabetes who were under follow-up in the same center for at least a year.

Primary Outcome Measures

Name	Time	Method
Glycemia control status of Turkish adult patients with diabetes mellitus	7 days	Glycemia control will be defined as good control if the mean HbA1c level of patients \< 7% or poor control if the mean HbA1c level of patient \> 7%

Secondary Outcome Measures

Name	Time	Method
Blood pressure control status of Turkish adult patients with diabetes mellitus	7 days	Home blood pressure \<135/85 mmHg will be defined as under control.
Weight control status of Turkish adult patients with diabetes mellitus.	7 days.	Body mass index \< 30 kg/m2 will be defined as under control. Weight and height will be combined to report body mass index in kg/m2.
Lipid control status of Turkish adult patients with diabetes mellitus.	7 days.	Triglyceride \< 150 mg/dl, LDL-C \< 100 mg/dl, HDL-C \> 40 mg/dl for men, and HDL-C \> 50 mg/dl for women will be defined as under control.

Trial Locations

Locations (1)

Gulhane School of Medicine Department of Endocrinology and Metabolism; 🇹🇷 Ankara, Turkey